Media formats available:
Recommended
- ACC.24
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
Michael Miller, MD
- Kidney DiseaseA multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy
Antoni Bayés-Genís, MD, PhD
Patrick Rossignol, MD, PhD
- Tackling the risk of hyperkalemia through guideline-recommended heart failure therapyPrescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF
Aaron Wong, MD